D-homo-aza-steroids
    42.
    发明授权
    D-homo-aza-steroids 失效
    D-同型 - 氮杂类固醇

    公开(公告)号:US3972884A

    公开(公告)日:1976-08-03

    申请号:US503564

    申请日:1974-09-06

    申请人: Charles D. Jones

    发明人: Charles D. Jones

    IPC分类号: C07J73/00 C07D215/12

    CPC分类号: C07J73/005

    摘要: New 14a-aza-D-homo-cholestane derivatives are useful as antifungal agents.

    摘要翻译: 新的14a-氮杂-D-胆固醇衍生物可用作抗真菌剂。

    24-Oxo-14a-aza-D-homo-cholestadiene derivatives
    43.
    发明授权
    24-Oxo-14a-aza-D-homo-cholestadiene derivatives 失效
    24-Oxo-14a-氮杂-D-胆甾烯二烯衍生物

    公开(公告)号:US3947453A

    公开(公告)日:1976-03-30

    申请号:US503565

    申请日:1974-09-06

    申请人: Charles D. Jones

    发明人: Charles D. Jones

    IPC分类号: C07J73/00 C07D215/06

    CPC分类号: C07J73/005

    摘要: Side chain modification of 24-hydroxyimino-14a-aza-D-homo-cholesta-8(9), 14(14a)-dienes provides novel azasteroids having antifungal activities.

    摘要翻译: 24-羟基亚氨基-14a-氮杂-D-胆固醇-8(9),14(14a) - 二烯的侧链修饰提供了具有抗真菌活性的新型氮氧自由基。

    Benzofuran compounds, compositions, and methods
    44.
    发明授权
    Benzofuran compounds, compositions, and methods 失效
    苯并呋喃化合物,组合物和方法

    公开(公告)号:US06703407B1

    公开(公告)日:2004-03-09

    申请号:US08309271

    申请日:1994-09-20

    IPC分类号: A61K31445

    CPC分类号: C07D307/80

    摘要: The present invention provides novel, reduced benzothiophenes of formula I wherein R is —H, —OH, —O(C1-C4 alkyl), —O—CO—(C1-C6 alkyl), —O—CO—Ar in which Ar is optionally substituted phenyl, or —O—SO2—(C4-C6 alkyl); R1 is —H, —OH, —O(C1-C4 alkyl), —O—CO—(C1-C6 alkyl), —O—CO—Ar in which Ar is optionally substituted phenyl, —O—SO2—(C4-C6 alkyl) chloro or bromo; n is 2 or 3; and R2 and R3 each are independently C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidino, dimethyl-1-pyrrolidino, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin, and intermediate compounds.

    摘要翻译: 本发明提供了新颖的式I的还原型苯并噻吩,其中R是-H,-OH,-O(C 1 -C 4烷基),-O-CO-(C 1 -C 6烷基),-O-CO-Ar 取代的苯基或-O-SO 2 - (C 1 -C 6烷基); R 1是-H,-OH,-O(C 1 -C 4烷基),-O-CO-(C 1 -C 6烷基) -CO-Ar,其中Ar是任选取代的苯基,-O-SO 2 - (C 1 -C 6烷基)氯或溴; n是2或3; R 2和R 3各自独立地为C 1 -C 4烷基,或者结合形成1-哌啶基,1-吡咯烷子基,1-吡咯烷子基,二甲基-1-吡咯烷子基,4-吗啉代或1-六亚甲基亚氨基; 或其药学上可接受的盐。 还提供了减轻绝经后综合征症状,抑制子宫内膜异位症,子宫纤维化和主动脉平滑肌细胞增殖的方法。 还提供了具有式I化合物的药物制剂,任选地包括雌激素或孕激素,以及中间体化合物。

    Benzofuran compounds, compositions, and methods
    47.
    发明授权
    Benzofuran compounds, compositions, and methods 失效
    苯并呋喃化合物,组合物和方法

    公开(公告)号:US06407243B1

    公开(公告)日:2002-06-18

    申请号:US08435437

    申请日:1995-05-10

    IPC分类号: C07D40510

    CPC分类号: C07D307/80

    摘要: The present invention provides novel compound of the formula: wherein Ra is —OH or —O—(C1-C4 alkyl); R1a is —OH or —O—(C1-C4 alkyl); n is 2 or 3; R2 and R3 are each independently: —C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidinyl, 1-pyrrolidinyl substituted with one or two methyl groups, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明提供下式的新化合物:其中R a是-OH或-O-(C 1 -C 4烷基); R 1a是-OH或-O-(C 1 -C 4烷基); n是2或3; R 2和R 3是 或其药学上可接受的盐,各自独立地为:-C 1 -C 4烷基,或结合形成1-哌啶基,1-吡咯烷基,被一个或两个甲基取代的1-吡咯烷基,4-吗啉代或1-六亚甲基亚氨基。